BofA/Merrill Lynch Downgrades Thoratec (THOR) to Neutral; Widespread Bad News
Tweet Send to a Friend
BofA/Merrill Lynch downgraded Thoratec (NASDAQ: THOR) from Buy to Neutral with a price target of $25.00 (from $41.00), saying the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
